Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics; antimalarials; dry syrups; ointments and creams; anti-diabetics; syrups; and miscellaneous products, as well as diuretics, antireterovirals, and steroidal preparations. It also exports its products. The company was incorporated in 1994 and is based in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 331 Cr
P/E 23.90
Div Yield 0.00 %
Book Value โน9.10
52w High โน57.00
52w Low โน30.20
Face Value โน2.00
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
69.40
56.81
58.68
52.64
38.25
41.30
39.49
39.35
30.80
41.32
29.77
42.36
31.47
Expenses
66.10
49.66
54.35
49.91
35.43
34.64
36.38
36.94
27.98
36.67
27.04
39.29
29.01
Operating Profit
3.30
7.15
4.33
2.73
2.82
6.66
3.11
2.41
2.82
4.65
2.73
3.07
2.46
OPM %
4.76
12.59
7.38
5.19
7.37
16.13
7.88
6.12
9.16
11.25
9.17
7.25
7.82
Other Income
1.17
2.87
0.68
1.72
0.66
0.29
1.43
0.68
0.29
0.58
0.27
0.96
0.31
Depreciation
0.72
0.80
0.79
0.73
0.77
0.77
0.76
0.75
0.75
0.74
0.72
0.71
0.71
Interest
0.41
0.90
0.39
0.24
0.28
0.49
0.28
0.21
0.18
0.25
0.22
0.18
0.17
Profit before tax
3.34
8.32
3.83
3.48
2.43
5.69
3.50
2.13
2.18
4.24
2.06
3.14
1.89
Tax %
24.55
29.69
25.07
25.86
25.51
23.90
25.14
27.23
27.06
26.89
30.10
22.61
29.63
Net Profit
2.52
5.86
2.87
2.57
1.82
4.34
2.62
1.55
1.58
3.10
1.45
2.43
1.32
EPS in Rs
0.30
0.71
0.35
0.31
0.22
0.52
0.32
0.19
0.19
0.37
0.17
0.29
0.16
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
206.00 151.00 145.00 140.00 121.00 122.00 89.00 98.00 61.00 54.00 67.00 51.00
Expenses
189.00 136.00 132.00 131.00 114.00 117.00 86.00 95.00 58.00 50.00 63.00 48.00
Operating Profit
17.00 15.00 13.00 10.00 7.00 5.00 3.00 3.00 3.00 4.00 4.00 3.00
OPM %
8.00 10.00 9.00 7.00 6.00 4.30 3.20 2.80 6.00 7.00 5.00 6.00
Other Income
6.00 3.00 2.00 4.00 2.00 1.00 2.00 2.00 1.00 0.00 0.00 0.00
Interest
2.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 2.00 1.00 1.00 1.00
Depreciation
3.00 3.00 3.00 3.00 2.00 2.00 2.00 2.00 1.00 1.00 1.00 1.00
Profit before tax
18.00 14.00 11.00 10.00 6.00 4.00 2.00 2.00 2.00 2.00 2.00 1.00
Tax %
27.00 25.00 27.00 28.00 26.00 30.00 26.00 28.00 35.00 4.00 40.00 28.00
Net Profit
13.00 10.00 8.00 7.00 5.00 3.00 2.00 2.00 1.00 2.00 1.00 1.00
EPS in Rs
1.58 1.22 1.00 0.87 0.58 0.31 0.20 0.19 0.15 0.25 0.35 0.25
Dividend Payout %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
17.00 17.00 17.00 17.00 17.00 4.00 4.00 4.00 4.00 3.00 2.00 2.00
Reserves
59.00 46.00 36.00 27.00 20.00 28.00 26.00 24.00 23.00 13.00 13.00 12.00
Borrowings
19.00 15.00 8.00 10.00 13.00 15.00 14.00 14.00 13.00 19.00 14.00 8.00
Other Liabilities
59.00 43.00 36.00 34.00 28.00 28.00 32.00 35.00 20.00 13.00 17.00 14.00
Total Liabilities
153.00 120.00 96.00 87.00 77.00 76.00 75.00 76.00 59.00 48.00 46.00 36.00
Fixed Assets
20.00 21.00 21.00 22.00 18.00 15.00 13.00 12.00 7.00 7.00 7.00 8.00
CWIP
3.00 0.00 0.00 0.00 0.00 0.00 2.00 1.00 4.00 3.00 0.00 0.00
Investments
2.00 2.00 2.00 1.00 0.00 1.00 0.00 0.00 0.00 0.00 1.00 1.00
Other Assets
129.00 96.00 73.00 64.00 59.00 59.00 60.00 63.00 48.00 39.00 38.00 27.00
Total Assets
153.00 120.00 96.00 87.00 77.00 76.00 75.00 76.00 59.00 48.00 46.00 36.00
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017
Cash from Operating Activity
6.00 5.00 2.00 8.00 6.00 -11.00 1.00 5.00 5.00 -3.00
Cash from Investing Activity
-5.00 -3.00 -3.00 -7.00 -2.00 -17.00 -3.00 -4.00 -5.00 -3.00
Cash from Financing Activity
-1.00 -1.00 0.00 -2.00 -6.00 18.00 3.00 -1.00 -1.00 6.00
Net Cash Flow
1.00 1.00 -1.00 0.00 -2.00 -10.00 0.00 0.00 0.00 0.00
Free Cash Flow
1.00 2.00 0.00 2.00 3.00 -28.00 -2.00 1.00 3.00 -4.00
CFO/OP %
64.00 58.00 43.00 111.00 104.00 -198.00 53.00 198.00 162.00 -68.00
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
145.00 138.00 125.00 94.00 92.00 82.00 98.00 109.00 102.00 122.00 107.00 53.00
Inventory Days
72.00 90.00 54.00 69.00 76.00 58.00 99.00 74.00 125.00 96.00 63.00 76.00
Days Payable
119.00 117.00 105.00 108.00 113.00 100.00 143.00 149.00 147.00 112.00 106.00 122.00
Cash Conversion Cycle
98.00 111.00 75.00 54.00 54.00 39.00 54.00 33.00 80.00 105.00 64.00 6.00
Working Capital Days
87.00 90.00 74.00 54.00 52.00 50.00 61.00 49.00 88.00 110.00 53.00 21.00
ROCE %
23.00 21.00 21.00 21.00 15.00 10.00 8.00 8.00 9.00 10.00 11.00 10.00
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
61.38
61.38
61.38
61.38
62.59
63.79
66.83
73.34
73.34
73.34
73.34
73.34
FIIs
0.08
0.03
0.49
0.30
0.07
0.11
0.39
0.22
0.22
0.29
1.29
1.11
DIIs
0.00
0.00
0.00
0.01
0.01
0.01
0.78
0.97
0.97
0.74
0.00
0.00
Public
38.55
38.60
38.13
38.30
37.33
36.08
32.00
25.47
25.46
25.63
25.36
25.55
No. of Shareholders
15,863
16,189
16,562
18,503
16,474
15,424
14,104
12,887
12,902
10,685
6,052
5,264
Corporate Actions
5 records
Back to all stocks